{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:48:51Z","timestamp":1784825331067,"version":"3.55.0"},"reference-count":67,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.8361","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T08:12:30Z","timestamp":1576829550000},"source":"Crossref","is-referenced-by-count":3,"title":["A patient\u2011centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single\u2011center observational study"],"prefix":"10.3892","author":[{"given":"Elena","family":"Rezus","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Physiotherapy, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Burlui","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Physiotherapy, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Gafton","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology\u2011Radiotherapy, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Stratulat","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology\u2011Radiotherapy, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Zota","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Clinical Pharmacology and Algesiology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Cardoneanu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Physiotherapy, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"Rezus","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"key20200713005832_b1-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front Immunol"},{"key":"key20200713005832_b2-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/BOR.0000000000000325","article-title":"Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis","volume":"28","author":"Choi","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"key20200713005832_b3-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3390\/ijms17071189","article-title":"Orofacial manifestations and temporomandibular disorders of systemic scleroderma: An observational study","volume":"17","author":"Crincoli","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20200713005832_b4-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/acr.22870","article-title":"Independent association of severity of muscle weakness with disability as measured by the health assessment questionnaire disability index in scleroderma","volume":"68","author":"Paik","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key20200713005832_b5-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/1756-0500-7-594","article-title":"Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses","volume":"7","author":"Bretterklieber","year":"2014","journal-title":"BMC Res Notes"},{"key":"key20200713005832_b6-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"e90484","DOI":"10.1371\/journal.pone.0090484","article-title":"Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: A cross-sectional survey","volume":"9","author":"Nguyen","year":"2014","journal-title":"PLoS One"},{"key":"key20200713005832_b7-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3899\/jrheum.150023","article-title":"Work disability in early systemic sclerosis: A longitudinal population-based cohort study","volume":"42","author":"Sandqvist","year":"2015","journal-title":"J Rheumatol"},{"key":"key20200713005832_b8-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kex182","article-title":"Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group","volume":"57","author":"Jaeger","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b9-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/rheumatology\/kew003","article-title":"The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis","volume":"55","author":"Ziemek","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b10-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13075-017-1250-z","article-title":"Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension","volume":"19","author":"Morrisroe","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"key20200713005832_b11-etm-0-0-8361","first-page":"S3","article-title":"Systemic sclerosis: From pathogenesis to targeted therapy","volume":"33","author":"Denton","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"key20200713005832_b12-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7861\/clinmedicine.16-1-55","article-title":"Advances in pathogenesis and treatment of systemic sclerosis","volume":"16","author":"Denton","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"key20200713005832_b13-etm-0-0-8361","doi-asserted-by":"crossref","first-page":"169","DOI":"10.37897\/RJR.2018.4.4","article-title":"Is there a place for anti-nucleosome antibody assessment in scleroderma?","volume":"27","author":"Burlui","year":"2018","journal-title":"Rom J Rheumatol"},{"key":"key20200713005832_b14-etm-0-0-8361","first-page":"588","article-title":"Effects of oxidative stress and pharmacologycal treatment on geriatric syndromes in the hospitalised elderly patients","volume":"64","author":"Ilie","year":"2016","journal-title":"Farmacia"},{"key":"key20200713005832_b15-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/ijms20030614","article-title":"The Link Between Inflammaging and Degenerative Joint Diseases","volume":"20","author":"Rezu\u0219","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20200713005832_b16-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2362.2009.02117.x","article-title":"Endothelin receptor selectivity: Evidence from in vitro and pre-clinical models of scleroderma","volume":"39","author":"Shiwen","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"key20200713005832_b17-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/phrs.1997.0246","article-title":"Highlights on endothelins: A review","volume":"36","author":"Ortega Mateo","year":"1997","journal-title":"Pharmacol Res"},{"key":"key20200713005832_b18-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1128\/MCB.00625-06","article-title":"Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: Evidence of an autocrine endothelin loop operating through the endothelin A and B receptors","volume":"26","author":"Shi-Wen","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key20200713005832_b19-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/ard.2008.094193","article-title":"Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis","volume":"69","author":"Mouthon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key20200713005832_b20-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5301\/jsrd.5000238","article-title":"The critical need for accurately defining digital ulcers in scleroderma","volume":"2","author":"Li","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"key20200713005832_b21-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/acr.20108","article-title":"Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis","volume":"62","author":"Schieir","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key20200713005832_b22-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.semarthrit.2017.01.001","article-title":"Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function","volume":"46","author":"Mouthon","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"key20200713005832_b23-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13075-015-0558-9","article-title":"Evaluation of the effect of ambrisentan on digital microvascular flow in patients with systemic sclerosis using laser Doppler perfusion imaging: A 12-week randomized double-blind placebo controlled trial","volume":"17","author":"Bose","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"key20200713005832_b24-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2174\/1570161113666150105112820","article-title":"Cardiovascular Risk Factors in Chronic Inflammatory Rheumatic Diseases: Modern Assessment and Diagnosis","volume":"13","author":"Rezu\u015f","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"key":"key20200713005832_b25-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"key20200713005832_b26-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3899\/jrheum.140236","article-title":"Systemic sclerosis sine scleroderma: A multicenter study of 1417 subjects","volume":"41","author":"Diab","year":"2014","journal-title":"J Rheumatol"},{"key":"key20200713005832_b27-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/00129784-200606030-00006","article-title":"Bosentan: A review of its use in pulmonary arterial hypertension and systemic sclerosis","volume":"6","author":"Oldfield","year":"2006","journal-title":"Am J Cardiovasc Drugs"},{"key":"key20200713005832_b28-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10067-005-1157-y","article-title":"A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis","volume":"25","author":"Nadashkevich","year":"2006","journal-title":"Clin Rheumatol"},{"key":"key20200713005832_b29-etm-0-0-8361","first-page":"2417","article-title":"Sildenafil for pulmonary arterial hypertension associated with connective tissue disease","volume":"34","author":"Badesch","year":"2007","journal-title":"J Rheumatol"},{"key":"key20200713005832_b30-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"key20200713005832_b31-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0735-1097(03)00463-7","article-title":"Beraprost therapy for pulmonary arterial hypertension","volume":"41","author":"Barst","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key20200713005832_b32-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled trial","volume":"39","author":"Gali\u00e8","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key20200713005832_b33-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/rheumatology\/ket377","article-title":"Cardiac arrhythmias and conduction defects in systemic sclerosis","volume":"53","author":"Vacca","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b34-etm-0-0-8361","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.37358\/RC.18.11.6739","article-title":"Preoperative Hemoglobin Dynamics in Patients with Trochanteric Fractures. A multivariate analysis","volume":"69","author":"Gheorghevici","year":"2018","journal-title":"Rev Chim Buchar"},{"key":"key20200713005832_b35-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"v17","DOI":"10.1093\/rheumatology\/kex193","article-title":"Functional disability and other health-related quality-of-life domains: Points to consider for clinical trials in systemic sclerosis","volume":"56","author":"Khanna","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b36-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/rheumatology\/ket441","article-title":"The Canadian systemic sclerosis oral health study: Orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population","volume":"53","author":"Baron","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b37-etm-0-0-8361","first-page":"26","article-title":"The role of adipokines in inflammation and connective tissue diseases: Can we face the challenge?","volume":"8","author":"Burlui","year":"2018","journal-title":"Int J Med Dent"},{"key":"key20200713005832_b38-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nut.2018.03.046","article-title":"Prevalence of sarcopenia in systemic sclerosis: Assessing body composition and functional disability in patients with systemic sclerosis","volume":"55-56","author":"Siegert","year":"2018","journal-title":"Nutrition"},{"key":"key20200713005832_b39-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/0394632015606846","article-title":"Digital ulcers in scleroderma patients: A retrospective observational study","volume":"29","author":"De Cata","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key20200713005832_b40-etm-0-0-8361","first-page":"307","article-title":"Effectiveness and safety of oxycodone\/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers: Two case reports","volume":"11","author":"Ughi","year":"2016","journal-title":"Clin Interv Aging"},{"key":"key20200713005832_b41-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40674-018-0104-4","article-title":"Pain and Its Management in Systemic Sclerosis","volume":"4","author":"Merz","year":"2018","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"key20200713005832_b42-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/jnr.23609","article-title":"Enhanced analgesic effects of tramadol and common trace element coadministration in mice","volume":"93","author":"Alexa","year":"2015","journal-title":"J Neurosci Res"},{"key":"key20200713005832_b43-etm-0-0-8361","first-page":"80","article-title":"The Impact of Public Health Care Services on the Patients' Perception as Regards the Health Institutions Brand on the Background of the Health Reform in Romania","volume":"49","author":"Luca","year":"2015","journal-title":"Rev Res Soc Intervention"},{"key":"key20200713005832_b44-etm-0-0-8361","first-page":"120","article-title":"The Crisis Impact on the Romanian Health System and Population Health","volume":"57","author":"Carausu","year":"2017","journal-title":"Rev Res Soc Intervention"},{"key":"key20200713005832_b45-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/rheumatology\/kex410","article-title":"Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study","volume":"57","author":"Peytrignet","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b46-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1136\/annrheumdis-2016-210503","article-title":"Treatment outcome in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study (ESOS)","volume":"76","author":"Herrick","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key20200713005832_b47-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"993","DOI":"10.4330\/wjc.v6.i9.993","article-title":"Cardiac manifestations in systemic sclerosis","volume":"6","author":"Lambova","year":"2014","journal-title":"World J Cardiol"},{"key":"key20200713005832_b48-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/rheumatology\/keu456","article-title":"Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis","volume":"54","author":"Wallace","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b49-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1183\/16000617.0063-2015","article-title":"Pulmonary arterial hypertension: The burden of disease and impact on quality of life","volume":"24","author":"Delcroix","year":"2015","journal-title":"Eur Respir Rev"},{"key":"key20200713005832_b50-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.autrev.2015.07.012","article-title":"Quality of life in systemic sclerosis","volume":"14","author":"Almeida","year":"2015","journal-title":"Autoimmun Rev"},{"key":"key20200713005832_b51-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13075-019-1842-x","article-title":"Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: A cross-sectional study","volume":"21","author":"Park","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"key20200713005832_b52-etm-0-0-8361","first-page":"1586","article-title":"The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis","volume":"33","author":"Mugii","year":"2006","journal-title":"J Rheumatol"},{"key":"key20200713005832_b53-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1513\/AnnalsATS.201606-426FR","article-title":"Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies","volume":"13","author":"Volkmann","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"key20200713005832_b54-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s40674-016-0052-9","article-title":"Hand impairment in systemic sclerosis: Various manifestations and currently available treatment","volume":"2","author":"Young","year":"2016","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"key20200713005832_b55-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","article-title":"Consensus best practice pathway of the UK Scleroderma Study Group: Digital vasculopathy in systemic sclerosis","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b56-etm-0-0-8361","first-page":"1164","article-title":"The impact of self-medication with NSAIDS\/analgesics in a North-Eastern region of Romania","volume":"62","author":"Alexa","year":"2014","journal-title":"Farmacia"},{"key":"key20200713005832_b57-etm-0-0-8361","first-page":"493","article-title":"The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: A double blind crossover study","volume":"5","author":"Finch","year":"1986","journal-title":"Clin Rheumatol"},{"key":"key20200713005832_b58-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","article-title":"Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis","volume":"44","author":"Thompson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"key20200713005832_b59-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key20200713005832_b60-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"e0124205","DOI":"10.1371\/journal.pone.0124205","article-title":"Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review","volume":"10","author":"Omair","year":"2015","journal-title":"PLoS One"},{"key":"key20200713005832_b61-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/rheumatology\/kel244","article-title":"Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis","volume":"46","author":"Nihtyanova","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b62-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/rheumatology\/40.1.84","article-title":"Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma","volume":"40","author":"Stratton","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713005832_b63-etm-0-0-8361","first-page":"287","article-title":"A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis","volume":"25","author":"Vanthuyne","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"key20200713005832_b64-etm-0-0-8361","first-page":"S87","article-title":"Treatment of early diffuse cutaneous systemic sclerosis patients in Japan by low-dose corticosteroids for skin involvement","volume":"22","author":"Takehara","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"key20200713005832_b65-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF00300808","article-title":"Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo-controlled study","volume":"14","author":"Sharada","year":"1994","journal-title":"Rheumatol Int"},{"key":"key20200713005832_b66-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: Results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key20200713005832_b67-etm-0-0-8361","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/rheumatology\/kep413","article-title":"Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: A double-blind prospective, randomized, placebo-controlled pilot study","volume":"49","author":"Nguyen","year":"2010","journal-title":"Rheumatology (Oxford)"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T14:31:08Z","timestamp":1613226668000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.8361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":67,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.8361","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]}}}